Incidental thyroid carcinoma in surgically treated multinodular goiter: a retrospective study - Top-Institutions - MDSpire

Incidental thyroid carcinoma in surgically treated multinodular goiter: a retrospective study

  • By

  • G. Pavone

  • E. Lamanna

  • M. Pacilli

  • E. Khoury

  • A. Ambrosi

  • N. Tartaglia

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Hospital “Ospedali Riuniti” of Foggia
    University Hospital “Ospedali Riuniti” of Foggia

    Foggia, Italy

    Key Differentiators

    • Endocrinology

  • #2

    Jagiellonian University Medical College
    Jagiellonian University Medical College

    Krakow, Poland

    Key Differentiators

    • Endocrinology

Original Source(s)

Incidental thyroid carcinoma in surgically treated multinodular goiter: a retrospective study

  • by G. Pavone, E. Lamanna, M. Pacilli, E. Khoury, A. Ambrosi, N. Tartaglia

  • July 2, 2026

Related Content

ASCO26: Atish Choudhury, MD, PhD, A-DREAM/Alliance A032101

A-DREAM/Alliance A032101 study presented by Dana-Farber Cancer Institute's Dr. Atish Choudhury shows 41% of favorable responders to testosterone suppression plus androgen receptor pathway inhibitor remaining treatment-free with testosterone recovery at 18 months after treatment interruption.

  • July 1, 2026

  • 1 min
Editorial: National Colorectal Cancer Awareness Month 2025: Current Progress and Future Prospects on Colorectal Cancer Prevention, Diagnosis and Treatment

ASCO26: Alicia Morgans, MD, MPH, ARACOG

Dr. Alicia Morgans of Dana-Farber Cancer Institute reported at #ASCO26 that ARACOG found darolutamide was associated with less decline in cognitive testing than enzalutamide, which may help guide treatment choice.

  • July 1, 2026

  • 1 min